| Resveratrol 3‐O‐d‐glucuronide and resveratrol 4′‐O‐d‐glucuronide inhibit colon cancer cell growth: Evidence for a role of A3 adenosine receptors, cyclin D1 … E Polycarpou, LB Meira, S Carrington, E Tyrrell, H Modjtahedi, MA Carew Molecular nutrition & food research 57 (10), 1708-1717, 2013 | 66 | 2013 |
| Identification of NAD (P) H quinone oxidoreductase activity in azoreductases from P. aeruginosa: azoreductases and NAD (P) H quinone oxidoreductases belong to the same FMN … A Ryan, E Kaplan, JC Nebel, E Polycarpou, V Crescente, E Lowe, ... PloS one 9 (6), e98551, 2014 | 60* | 2014 |
| Overcoming the blood-brain barrier: Functionalised chitosan nanocarriers AE Caprifico, PJS Foot, E Polycarpou, G Calabrese Pharmaceutics 12 (11), 1013, 2020 | 50 | 2020 |
| Cosm-nutraceutical nanovesicles for acne treatment: Physicochemical characterization and exploratory clinical experimentation SS Amer, M Nasr, RTA Abdel-Aziz, NH Moftah, A El Shaer, E Polycarpou, ... International journal of pharmaceutics 577, 119092, 2020 | 50 | 2020 |
| Stainless steel with tailored porosity using canister-free hot isostatic pressing for improved osseointegration implants H Hassanin, AA Al-Kinani, A ElShaer, E Polycarpou, MA El-Sayed, K Essa Journal of materials chemistry B 5 (47), 9384-9394, 2017 | 29 | 2017 |
| Quercetin loaded cosm-nutraceutical electrospun composite nanofibers for acne alleviation: Preparation, characterization and experimental clinical appraisal SS Amer, W Mamdouh, M Nasr, A ElShaer, E Polycarpou, RTA Abdel-Aziz, ... International Journal of Pharmaceutics 612, 121309, 2022 | 25 | 2022 |
| Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan‐Based Nanocarriers AE Caprifico, E Polycarpou, PJS Foot, G Calabrese Macromolecular Bioscience 21 (1), 2000312, 2021 | 23 | 2021 |
| Overcoming the protein corona in chitosan-based nanoparticles AE Caprifico, PJS Foot, E Polycarpou, G Calabrese Drug Discovery Today 26 (8), 1825-1840, 2021 | 22 | 2021 |
| Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti‐tubercular agents using a fragment‐based drug design approach A Ryan, E Polycarpou, NA Lack, D Evangelopoulos, C Sieg, A Halman, ... British journal of pharmacology 174 (14), 2209-2224, 2017 | 22 | 2017 |
| Identification of novel members of the bacterial azoreductase family in Pseudomonas aeruginosa V Crescente, SM Holland, S Kashyap, E Polycarpou, E Sim, A Ryan Biochemical Journal 473 (5), 549-558, 2016 | 22 | 2016 |
| Fluorescein isothiocyanate chitosan nanoparticles in oral drug delivery studies AE Caprifico, E Polycarpou, PJS Foot, G Calabrese Trends in Pharmacological Sciences 41 (10), 686-689, 2020 | 20 | 2020 |
| Advances in chitosan-based CRISPR/Cas9 delivery systems AE Caprifico, PJS Foot, E Polycarpou, G Calabrese Pharmaceutics 14 (9), 1840, 2022 | 12 | 2022 |
| Efficacy of cannabinoids against glioblastoma multiforme: A systematic review I Kyriakou, N Yarandi, E Polycarpou Phytomedicine 88, 153533, 2021 | 8 | 2021 |
| Metabolites of cannabis induce cardiac toxicity and morphological alterations in cardiac myocytes AO Merve, P Sobiecka, V Remeškevičius, L Taylor, L Saskoy, S Lawton, ... International Journal of Molecular Sciences 23 (3), 1401, 2022 | 7 | 2022 |
| Cocaine addicted to cytoskeletal change and a fibrosis high A Verma, J Bennett, AM Örme, E Polycarpou, B Rooney Cytoskeleton 76 (2), 177-185, 2019 | 7 | 2019 |
| Cocaine induces cytoskeletal changes in cardiac myocytes: Implications for cardiac morphology A Verma, A Orme Merve, V Remeškevičius, P Sobiecka, L Taylor, ... International Journal of Molecular Sciences 22 (5), 2263, 2021 | 3 | 2021 |
| Arylamine N-Acetyltransferases N Laurieri, E Polycarpou, E Sim Elsevier, 2018 | 2 | 2018 |
| Full wwPDB X-ray Structure Validation Report i Y Kim, KH Kim | 1 | 2023 |
| Arylamine N-Acetyltransferases S Boukouvala, G Fakis, I Stavrakaki, E Polycarpou, N Laurieri, E Sim Elsevier, 2024 | | 2024 |
| Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems. Pharmaceutics 2022, 14, 1840 AE Caprifico, PJS Foot, E Polycarpou, G Calabrese s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
